The binding free energy of 4-bromophenol (4-BP), an inhibitor that binds in the internal binding site in dehaloperoxidase-hemoglobin (DHP) was calculated using Molecular Dynamics (MD) methods combined with pulling or umbrella sampling.
Introduction
The binding of an inhibitor, 4-bromophenol (4-BP), in a well-defined binding site in the distal pocket of the multi-functional enzyme dehaloperoxidase-hemoglobin (DHP) from Amphitrite ornata presents an interesting set of biological questions while simultaneously providing a well-defined model system to test computational methods for the calculation of binding free energy. [1, 2] The nature of the binding trajectory is of interest since 4-BP must displace a number of amino acid side chains in DHP in order to enter or exit the distal pocket. The modeling of the trajectory using molecular dynamics (MD) simulations has the same features observed in the general class of calculations of drug and ligand binding [3, 4] and is particularly closely related to the binding of substrates to cytochrome P450. [5] [6] [7] [8] [9] Since 4-BP is relatively rigid, having only the bending and torsions of the hydroxyl group as internal degrees of freedom, the parameters are relatively easily incorporated into the force field for studies of the binding pathway using and the free energy via the potential of mean force (PMF) calculated using steered molecular dynamics (SMD) simulations. This makes the problem similar to the binding of small molecules such as diatomic ligands (CO, NO, O 2 ), indazole or nicotinic acid, which have also been studied using similar 4 methods. [10] [11] [12] [13] [14] However, the inhibitor, 4-BP, is significantly larger than a diatomic molecule and therefore the results have more relevance for binding free energy calculations in drug-target or ligand-receptor systems. The calculations the free energy of binding using non-equilibrium methods has been demonstrated using a variety of systems, many of them with far greater complexity that the DHP + 4-BP combination. [5, 6, 11, [15] [16] [17] [18] [19] [20] When the ligand has significant internal degrees of freedom, such as in peptide-protein or protein-protein binding, correction terms must be applied to thermodynamic integration used to extract the free energy from the simulated trajectory. [21] [22] [23] [24] By contrast the DHP + 4-BP system consists of a small rigid molecule that nonetheless has a well-defined internal binding pocket based on X-ray crystal structures ( Figure 1 ). [1, [25] [26] [27] [28] [29] [30] [31] [32] [33] In this study the restraints applied to the DHP protein are systematically reduced and ultimately compared to a restraint-free calculation. The systematic approach reveals a trade-off in the large magnitude of fluctuations in the calculated free energy and the increase in tractability as DHP is more restrained. [34] The selection of an appropriate free energy calculation method is important for modeling the DHP + 4-BP binding process, and can affect the calculated binding energy. Several methods are present in the literature that permit the calculation free energy differences from equilibrium MD simulation trajectories, such as thermodynamic integration, free energy perturbation (FEP), [4] and umbrella sampling (US) employing the weighted histogram analysis method (WHAM). [35] 5 These equilibrium methods can provide an accurate estimation of protein-ligand binding affinities, but they are only applicable if the system is sufficiently rigid so that the various stages of the trajectory have comparable geometries. An alternative non-equilibrium method based on the Jarzynski equality [36, 37] , the so-called "fast growth" method, [38] has been developed for free energy calculations as well. The Jarzynski equality has been employed to extract free energy profiles from repeated non-equilibrium pulling trajectories. [39] [40] [41] [42] [43] [44] [45] The non-equilibrium SMD method is considered less accurate than equilibrium US methods. [15, 46, 47] However, there are two advantages of the non-equilibrium method in free energy calculations compared to equilibrium methods: i) Non-equilibrium binding (or unbinding) simulations can be conducted for any value of the restraint force constant; ii) The method permits a relatively rapid test of different binding trajectories, which is relevant to the mechanism of protein-ligand interactions. [12, [48] [49] [50] The advantages of the SMD method can be used to study DHP ligand binding.
DHP is a multifunctional protein, which has documented functions as a globin (oxygen transport), peroxidase (electron transfer), peroxygenase (oxygen atom transfer) and an oxidase (oxidation by O 2 ). [51] The peroxygenase function has similarity with cytochrome P450 since both involve O atom transfer in their mechanism. The difference is that the O atom in P450 comes from bound O 2 , while that in DHP comes from bound H 2 O 2 . However, the distal pocket of DHP has not been thoroughly investigated as a ligand binding pocket in the way that the binding pocket of P450 has been studied. In fact, the idea of such an investigation would have been 6 considered impossible prior to the recent discovery that DHP has multiple internal binding sites, [52, 53] which makes its distal pocket more like the substrate binding pocket of a P450 than a typical globin. The paths for entry and exit of small molecules have been demonstrated based on the cytochrome P450 model system. [5] [6] [7] [8] [9] 54] In DHP, the inhibitor, 4-BP, is completely enveloped by the protein in the bound state just like substrates in P450. [1, 25] However, the binding of 4-BP appears to be quite specific since the para bromine atom of 4-BP is stabilized by a protein cavity [55, 56] and the hydroxyl group forms a hydrogen bond with the heme propionates. Since the trajectory of the inhibitor as it exits the distal pocket is relatively short in DHP, SMD is an appropriate method to test the relevance of specific exit pathways. The conclusions were validated using Umbrella Sampling (US) and Random Accelerated Molecular Dynamics (RAMD). [7] [8] [9] The contemporary idea of a tunnel for small molecule entry and exit trajectories derives from the early simulations using CO in myoglobin. Protein channels or tunnels have been identified in DHP based on the X-ray crystal structure coordinates (using programs CAVER [57] and MOLE. [58] ) and we have used this approach to understand the possible ligand trajectories in DHP. [59] Tunnels have been used to study a range of problems based on non-equilibrium simulations including discrimination between NO and O 2 in guanylate cyclase, [60] binding of ligands to cytochrome P450. [13] Both of these have relevance for DHP, where 4-BP must enter and exit the protein, but so too must O 2 and H 2 O 2 in order for DHP to carry out its various functions. For more than 30 years, the trajectories of photolyzed carbon 7 monoxide (CO) in Sperm whale myoglobin (SWMb) have been studied using MD simulations as a model system for protein dynamics. [61] [62] [63] [64] [65] [66] [67] For sufficiently long simulations on contemporary computer clusters, the CO molecule can be observed to escape from the protein, but 4-BP is not likely to escape on the time scales available in a typical MD simulation (~ 1 s). On the other hand, 4-BP is well suited for methods that permit calculation of a PMF, SMD and US because it is relatively rigid, thus simplifying the thermodynamic integration is required to extract a free energy that can be compared to experiment.
The goal of the present study has both a practical aspect and a fundamental aspect. From a practical point of view we would like to find a method that will permit us to compare the binding of substrates and inhibitors, since we now have evidence for binding of more than ten different molecules in the distal pocket. DHP functions as a monomer in the coelom of the marine worm, A. ornata, as shown by small angle X-ray scattering. [68] Using this monomer model system and the rigid inhibitor 4-BP, we will determine the trajectory with the smallest work for extraction of 4-BP from the protein, which is the most likely path for ligand exit. Free energy calculations based on either SMD or US use restraints, biasing, or fixed coordinates to eliminate high energy paths that are not physically reasonable. While equilibrium simulations, particularly US are considered to be the most accurate, a number of methods have been used to increase the accuracy of SMD simulations. Methods based on bi-directional pulling have complemented these efforts in an attempt to increase the applicability of the non-equilibrium methods to free energy calculations. [69] A 8 renormalization approach has been proposed to permit application of SMD to long-time dynamics on the microsecond time scale, which would increase the sampling and therefore the accuracy of thermodynamic averages. [70] The use of local sampling implemented using conformational freezing has been considered as a method to enhance the accuracy of the calculated PMF. [71] Biasing potentials have been implemented that restrict the conformation of ligands to their bound state. [72] Moreover, hybrid MD using a combination of docking and SMD with a scoring function has been proposed to solve these problems for drug delivery applications. [73] In this report, we have used SMD as a method to both establish the reaction path for inhibitor binding and to calculate the free energy. We have addressed the accuracy of the method by comparison with US and by a systematic study of the effect of restraints. Reasonable agreement with experiment is obtained when correction for the restraints are applied.
Methods

Molecular Dynamics Simulations
All the simulations were performed in the NVT ensemble at a temperature of 298 K. All the MD simulations were performed using the GROMACS package (version 4.5.2). [74, 75] The DHP and 4-bromophenol, the DHP-inhibitor complex, were modeled with the all-atom CHARMM27 [64] forcefield and water was modeled using the TIP3P [76] forcefield. The initial coordinates of the DHP-inhibitor complex were obtained from the protein data bank (PDB code: 3LB2). [1] . A DHP monomer The time step was chosen to be 2 fs consistent with use of the SHAKE algorithm. [77, 78] Periodic boundary conditions were applied in all directions.
Particle-mesh Ewald (PME) [79] summation was applied for treatment of the long-range coulomb interactions. The cutoff distance was chosen to be 1.3 nm. Initial velocities according to Maxwell distribution corresponding to the desired temperature were used as the starting configuration. In order to approach reasonable sampling each trajectory studied consisted of 100 averages of a 20 ns pulling simulation or 2 s of total simulation time per averaged trajectory. The Visual Molecular Dynamics (VMD) [80] program was used to visualize the output.
Orientation of the protein and inhibitor system for pulling simulations
The DHP protein was rotated such that the pulling vector is generally in the x-direction. It was assumed that the inhibitor would need to exit the distal pocket in the direction of the heme -edge, which is the shortest path for exit from the protein. The DHP + 4-BP system provides an opportunity to test the role of restraints.
Since 4-BP has very limited degrees of freedom, because only the hydroxyl H atom has a torsional motion in 4-BP, no restraints are needed for the inhibitor. The protein backbone restraints were applied to each C, CA and N atom in the sequence except the backbone atoms of residues K51 and P75 above the  edge. Those amino acids
were not restrained to permit adjustments in the structure during the passage of the inhibitor through the protein. The pulling force constant has a significant effect on the stability of the less restrained SMD simulations. If the pulling force constant was set larger than 600 kJ/(mol nm 2 ) the simulations had large fluctuations in the PMF and sometimes failed completely as the restraint force constant was reduced. When pulling force constant was set to 2400 kJ/(mol nm 2 ) the simulations had a failure rate of 50% prior to the normal 20 ns endpoint. GROMACS is quite robust and the failure rate of pulling simulations is normally < 1%. There were no failures observed for calculations using a frozen backbone so it was assumed that this problem is a 13 consequence of the distortion of the protein under certain conditions where the pulling force constant exceeds the restraint force constant.
A study of the effect of the pulling force constant on the PMF was conducted for an unrestrained protein calculation. The values for the pulling force constant used were 300, 600, 1200, 2400 and 8000 kJ/(mol nm 2 ). Beyond the fact that there was an apparent instability for high values of the pulling force constant, no significant difference in the calculated PMF was found for different values of the pulling force constant less than 2400 kJ/(mol nm 2 ). The PMF was studied by SMD as a function of the restraint force constant from 5, 10, 200, 500, 1000 kJ/(mol nm 2 ) using a pulling force constant of 1200 kJ/(mol nm 2 ).
The inhibitor pulling velocity of 0.1 nm/ns was determined based on a study of pulling velocity presented in the Supporting Information. Figure S3 shows that velocities of 0.2 and 0.5 nm/ns provide a PMF that is significantly higher than 0.1 nm/ns. Figure S4 shows that there is no change in PMF as the pulling velocity is lowered from 0.1 to 0.05 and 0.02 nm/ns, which validates the use of a pulling velocity of 0.1 nm/ns in the results presented below.
Using non-equilibrium pulling simulations to determine the binding pathway
One application of non-equilibrium pulling simulations is to determine the pathway used for entry and exit from the protein. It is difficult to experimentally verify such a determination other than to use the criterion that the minimum work 14 done, i.e. minimum PMF is most likely to be the correct choice. Three pathways were defined for comparison. The direction of pathway 1 is along the vector from Br atom to the O atom in the hydroxyl group of the 4-BP molecule in the X-ray crystal structure (PDB 3LB2).
[1] Figure 1 shows that the 4-BP trajectory in pathway 1 leads to exit through a gap between H55 and the -edge of the heme. Pathway 2 is parallel to the vector from the Fe atom to the -edge meso-carbon ( Figure 1 and Figure S1 ).
Residues K51 and H55 (marked in orange in Figure 1 ) are the main source of resistance in both of these exit pathways. Extensive experiments using diatomic ligands suggest that passage near H55 is the dominant pathway for water and diatomic ligands as they enter and exit the distal pocket. [28, 86] The above two choices for the pulling vector were contrasted with a third possible choice, which involves exit through the -edge of the heme ( Figure 1 and Figure S1 ). The -edge of the heme has been implicated as the binding site in a number of peroxidases, which are related to DHP in terms of function, but not in terms of structure.
Free energy calculation by Umbrella Sampling
As a reference of comparison to the SMD results, the umbrella sampling with WHAM was also performed to calculate the free energy profile for the DHP-inhibitor separation using a restraint force constant of 1000 kJ/(mol nm 2 ). The PMF was calculated along the pathway 1. The total path with a length of 2 nm was divided into 0.1 nm wide equidistant windows. There were no additional restraints on the 4-BP molecule in y and z-axis directions. The convergence within each window was 15 checked ( Figure S5 ) and overlap of the windows was also confirmed ( Figure S6 ). [46] The corresponding validations of convergence and overlap for the frozen backbone method are given in Figures S7 and S8 , respectively. To enhance sampling, the biased simulations were performed in 20 sampling windows, in which the center of mass of 4-BP was restrained along the pathway with a harmonic force constant of 600 kJ/(mol nm 2 ). As the same with the non-equilibrium method, the backbone atoms of the DHP molecule were harmonically restrained with a force constant of 1000 kJ/(mol nm 2 ) in
x, y and z-axis (with the exception of the residues from K51 to P75 as discussed above for the SMD simulation). In each umbrella simulation window, a MD simulation of 14 ns was performed for WHAM procedure, in which the method of Bayesian bootstrapping of complete [35] is carried out to estimate the statistical uncertainty of the PMF profile. The biased ligand distributions obtained from the production runs are then unbiased and combined using WHAM to obtain the PMF of the ligand by the following equation (Eqn. 2): 
Results
SMD simulations along three pathways analyzed by the Jarzynski equality
In order to obtain the lowest energy pathway for inhibitor exit from the distal pocket, we compared the calculated PMF using the Jarzynski equality along three pathways.
A series of SMD simulations were performed along each of the three pulling vectors shown in Figure 1 and Figure S1 using a frozen backbone model. Only the  and  heme edges have openings that are conceivable routes that would permit the inhibitor to pass (see Figure S1 for heme nomenclature). Two possible exit pathways for 4-BP through the  edge were found in a preliminary study using a partially frozen backbone (see Figure S2) . A third pathway via the  edge was considered to be of possible physiological relevance and was added for completeness. However, the pulling simulation along pathway 3 (directed to pass over the  edge of the heme) was observed to result in exit of 4-BP through the  edge instead. The calculated PMF in that case was significantly higher than for the other two pathways ( Figure S8 ), but this energy reflects the deviation of the inhibitor from intended pathway rather than an estimate of the barrier for passage over the  edge. It was concluded that transit of the inhibitor along a pathway over the  edge must be significantly higher in energy than those in the focus on a detailed comparison of pathways 1 and 2. The calculated PMFs shown in Figure S2 of the Supporting information indicate that pathway 1 has the lowest barrier for ligand exit. Therefore pathway 1 received further detailed study, because it is considered to be the best model for the physiologically relevant pathway found by the current methods. Regardless of the pulling vector, we find that the inhibitor must exit through an opening below H55 such that the inhibitor lies flat on the heme. If the vector is suboptimal the energy is much higher since the inhibitor crashes into amino acids of the distal pocket as it gropes its way towards the opening shown in Figure 3 . For example, the significant increase in the free energy along pathway 2 results from the dislocation of residues H55 and K51 by the passage of 4-BP along this pathway. The increase in energy and distortion is even more extreme along pathway 3, but even for that pulling vector, which is orthogonal to pathway 1, the exit of 4-BP is still observed through the same opening beneath H55 and along the surface of the heme. Since the PMF of pathway 1 is the most direct pathway to this exit portal it is deemed to be the best model for inhibitor exit. Therefore, pathway 1 was further studied by US to validate the results of the calculation using the Jarzynski equality.
Validation using umbrella sampling
In order to establish a reference point for comparison with the non-equilibrium methods used in this study, the binding free energy of the DHP-inhibitor complex was calculated via US using equilibrium MD trajectories along trajectory 1. Figure 4 shows the PMF of the DHP-inhibitor separation process by umbrella sampling. The PMF obtained from US suggests a total free energy difference of 83±3 kJ/mol, which is significantly lower than the PMF calculated using SMD simulations with a frozen backbone (107±5 kJ/mol). The overlaps for the various sampling windows and their convergence is presented in the Supporting Information. Figures S4 and S5 show the values for the frozen backbone and Figures S6 and S7 show the values for the calculation with a restraint force constant of 1000 kJ/(mol nm 2 ). These are not significantly different, which is also consistent with the SMD results shown in Figure   5 . We attempted to reduce the restraints for the US simulation as was done for the SMD. However, the individual window distribution functions became very broad when the restraints were reduced to 600 kJ/(mol nm 2 ).
Intuitively, it makes sense that US will work well for calculation of the binding free energy as long as the binding molecule is restrained to be close to the target value for the windows of the umbrella simulation. In US the biasing force constant causes the inhibitor to fluctuate about a structure comprising a fixed distance between the protein and ligand. The distance must be well-defined, which means that the fluctuations of the inhibitor cannot be too large. If the biasing force constant is significantly below 1000 kJ/(mol nm 2 ) the distribution of structures becomes so large 20 that the WHAM analysis becomes impossible to execute. A systematic comparison of US as a function of pulling force constant fails for this reason. Realizing this we did not further pursue the reduction of the force constants using US and instead turned to a systematic comparison of the PMF calculated using the Jarzynski equality for various values of the restraint force constants. is significantly higher in energy than the principal one identified by SMD.
Validation using Random Accelerated Molecular Dynamic (RAMD) simulations
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Calculation of the PMF as function of the pulling speed
The SMD should be stable for pulling speeds that are sufficiently slow, so that the molecule can remain in equilibrium during the course of the simulation. Obviously, if the pulling speed is too great there will be irreversible changes in the system and will introduce artifacts into the simulation. hus, there is an optimum speed, which is the most rapid pulling spend possible that permits the system to remain in equilibrium.
The systematic tests shown in Figures S2 and S3 reveal that the pulling speed of 0.1 nm/ns is the optimum for the SMD simulations. Thus, the simulation time used in these studies is 20 ns per simulation given that the pulling distance for the inhibitor was 2 nm from the initial position inside the protein.
Calculation of the PMF as function of the pulling force constant
The first approximation was a frozen backbone simulation as discussed above, which was used to determine the lowest energy pathway for exit of the inhibitor. A pulling force constant of 8000 kJ/(mol nm 2 ) was used for these simulations. Although this pulling force constant worked well for the frozen backbone simulation, it did not work particularly well for lower values of the restraint force constant. While the magnitude of the pulling force constant did not have a large effect on the calculated value of the PMF does affect the stability of the trajectory. After trials using 8000, 2400, 1200 and 600, 300 kJ/(mol nm 2 ) for the pulling force constant, the value of 22 1200 kJ/(mol nm 2 ) was finally chosen for the systematic study of restraint force constants described in the next section.
Calculation of the PMF as function of the protein backbone restraint
Although restraints are often applied to pulling simulations, they present an artificial restriction that may result in systematic error in the calculated PMF. In order to systematically test the effect of restraints, the pulling simulations shown in Figure 5 were carried out with restraints backbone restraints in the series 1000, 500, 200, 10, 5
and 0 kJ/(mol nm 2 ). The PMFs shown in Figure 5 are an average of 100 trajectories.
For the pulling simulation with no constraints 200 trajectories were averaged, because of the much larger variety of DHP confirmations sampled in the absence of restratint. 
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There is a disparity between the apparent convergence of the trend of decreasing restraints and the simulation with no restraints. If calculation without restraints is not considered it would appear that there is a trend towards a value of ca. 80 kJ/mol for the PMF as k r → 0. However, the PMF of the simulation without restraints is 53 kJ/mol, which clearly does not agree with the trend. The origin of this discrepancy is not known at the present time. A universal issue for MD simulations is the possibility that greater sampling is needed to obtain robust average values.
Discussion
There are three significant findings in the present study. First, the results collectively show that the SMD approach can provide a method for the calculation of the pathways for ligand binding. Second, we find that it is possible to estimate the effect of restraints on the PMF by a systematic study of the energetic effect of the restraint force constant. Third, we find the reasonable agreement between simulation and experiment can obtained.
Use of SMD to determine pathways in DHP
There have been numerous proposals for increasing the utility of SMD for application of the calculation of the free energy of binding. Yamashita and Fujitani recognized the complexity of binding trajectories in the lysozyme-antibody binding process and recommended the use of multi-step targeted MD instead of SMD. [90] This approach is combined with biasing constraints [5, 17, 40, 42, [91] [92] [93] or random expulsion potentials [7, 8] 
Use of SMD to systematically test the effect of restraint force constants
The results suggest that SMD is an appropriate method for systematic study of the effects of restraint force constants on the calculated PMF. As a corollary to the study of the effect of the restraint force constant we have obtained a simulation of the fully unrestrained PMF using 200 trajectories averaged trajectories. Even this number of trajectories may not provide sufficient sampling to obtain convergence for the unrestrained system, but the value obtained is reasonable and shows the potential for 25 such calculations (see Figure 5 and Figures S9-S11 for the standard deviations for these calculations).
There is a significant difference between the calculated PMF in the limit as the restraint force constant, k r → 0 and in the unrestrained calculation. This suggests that additional sources of error must be considered. Protein rotation and drift can occur in the unrestrained simulation, which may introduce artifacts in the calculated PMF. As with any approach using MD, sufficient sampling can provide an appropriate thermodynamic average. On the other hand, there are also possible artifacts in simulations that have restraints since these simulation may artificially restrict motion and thereby skew the sampled conformational distribution. Regardless of these potential problems the best agreement with experiment was obtained for the unrestrained simulation.
The appropriateness of DHP(4-BP) binding for systematic SMD studies
Clearly, the applicability of the SMD approach is system dependent. If either the protein or ligand has a large number of internal degrees of freedom, it is possible that the pulling force used in SMD could interfere with these motions and cause artifacts that decrease the accuracy of the free energy calculation. [15] [16] [17] 46] The interference is particularly large when there is a large electrostatic component to the binding free energy. [94] [95] [96] [97] However, it may also be a problem when both protein and ligand have significant internal degrees of freedom. For these reasons we have focused on a 
The significance of restraints in umbrella sampling
Umbrella sampling (US) has become a very popular method for calculation of binding free energies. [93] US is implemented as a number of simulations in windows at defined distances along the pulling pathway. In each window a biasing force constant tethers the inhibitor to keep it within the range of distances defined by the window according to a biasing potential. In the simulations carried out on the DHP(4-BP) binding pair 20 windows were used, which were spaced 1 nm apart (see Figures S5 and S7 ). An idealized view of the Gaussian distribution for this set of windows is shown in Figure S11A . The Gaussian nature of the distribution results
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naturally from the quadratic form of the biasing potential and a theoretically Gaussian form for the histogram of conformations in each window (see Figure S11) . [105] The potential. In order to carry out the WHAM procedure for averaging there must be appropriate overlap of overlap is too small then there is no continuity, but if the distribution is too broad then the method loses resolution to distinguish regions of the trajectory. [105] Reducing the biasing force constant to values below 1000 kJ/(mol nm 2 ) resulted in significant broadening of the distribution, which was not considered useful for further study.
The number of windows along the pulling trajectory must be sufficiently large to map out the change in mean force if one is to obtain a meaningful PMF from an US simulation. Since the breadth of the sampled conformational distribution depends on both the biasing and the restraint force constants, Figure S11 shows one cannot systematically decrease the force constants of the sampled distribution in the same 30 way that we have done for the SMD simulation without broadening the distributions to the point where the US simulation becomes meaningless. For this reason one cannot conduct the control calculation in which the restraints are systematically lowered since the fluctuations become so large that the simulation no longer converges.
The significance of restraints in steered molecular dynamics
Based on the preceding considerations it appears that SMD presents the possibility of systematic study of the effect of pulling and restraint force constant. As
Ytreberg has pointed out the effect of the restraint force constant on the free energy can be calculated using two correction terms.
[50]
The work term − ( ) is calculated as the potential of mean force (PMF). The first correction term, ∆ ℎ , can be obtained from equilibrium methods, in which the potential energy of the protein is obtained as the restraint force constant is systematically increased in the same manner as the parameter  is increased from 0 to 1 in free energy perturbation calculations. The second term consists of a product of the apo integral, which can be calculated analytically using the geometry of the system weighted by the equilibrium energy of the protein and ligand as a function of the pulling trajectory. When there are no restraints, the correction terms are zero and ∆ = − ( ), which means that ∆ = − . [50] Thus, a restraint-free 31 simulation can be directly compared to experiment. Using the approach of systematically lowering the magnitude of the restraints to estimate the magnitude of their contribution we find that the contribution of the restraints is ~50 kJ/mol. This value is nearly equal to the absolute magnitude of the experimentally measured binding free energy. We find that corrections for the restraints are significant even for small molecule binding equilibria, in accord with the conclusion that has been reached for the more complex case of protein-protein binding equilibria. [21, 22, 44, 50] 
Conclusion
We have addressed methods that can be used to calculate the free energy of 
